Handelsbanken Fonder’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.8M Buy
133,971
+14,919
+13% +$3.1M 0.09% 188
2026
Q1
$25.2M Buy
119,052
+1,440
+1% +$310K 0.08% 202
2025
Q4
$24.2M Sell
117,612
-370
-0.3% -$69.6K 0.07% 230
2025
Q3
$18.5M Sell
117,982
-830
-0.7% -$128K 0.06% 276
2025
Q2
$20M Buy
118,812
+77,104
+185% +$11.4M 0.07% 249
2025
Q1
$5.75M Buy
41,708
+1,925
+5% +$245K 0.02% 410
2024
Q4
$4.71M Buy
39,783
+4,140
+12% +$483K 0.02% 446
2024
Q3
$3.94M Sell
35,643
-6,882
-16% -$720K 0.02% 478
2024
Q2
$4.18M Sell
42,525
-71,723
-63% -$7.31M 0.02% 445
2024
Q1
$12.8M Buy
114,248
+388
+0.3% +$41.9K 0.06% 308
2023
Q4
$11.5M Sell
113,860
-12,905
-10% -$1.28M 0.06% 307
2023
Q3
$11M Sell
126,765
-86,133
-40% -$7.79M 0.06% 301
2023
Q2
$20.1M Sell
212,898
-1,900
-0.9% -$160K 0.11% 211
2023
Q1
$16.2M Buy
214,798
+6,349
+3% +$479K 0.09% 241
2022
Q4
$16M Sell
208,449
-479
-0.2% -$36.4K 0.1% 231
2022
Q3
$13.9M Buy
208,928
+41,439
+25% +$2.63M 0.09% 221
2022
Q2
$8.76M Buy
167,489
+52,594
+46% +$2.99M 0.06% 313
2022
Q1
$6.51M Buy
114,895
+7,646
+7% +$409K 0.04% 415
2021
Q4
$5.52M Sell
107,249
-2,641
-2% -$130K 0.03% 459
2021
Q3
$5.43M Buy
109,890
+6,272
+6% +$340K 0.03% 464
2021
Q2
$5.92M Buy
103,618
+28,004
+37% +$1.64M 0.03% 459
2021
Q1
$4.59M Buy
75,614
+8,021
+12% +$443K 0.03% 446
2020
Q4
$3.62M Hold
67,593
– – 0.02% 484
2020
Q3
$3.17M Hold
67,593
– – 0.02% 453
2020
Q2
$3.53M Buy
+67,593
New +$3.48M 0.03% 409
2018
Q2
– Sell
-136,166
Closed -$8.54M – 207
2018
Q1
$8.54M Buy
+136,166
New +$9.34M 0.17% 123
2017
Q2
– Sell
-29,875
Closed -$2.44M – 170
2017
Q1
$2.44M Hold
29,875
– – 0.07% 142
2016
Q4
$2.15M Sell
29,875
-10,000
-25% -$723K 0.07% 132
2016
Q3
$3.1M Sell
39,875
-4,000
-9% -$323K 0.09% 135
2016
Q2
$3.42M Hold
43,875
– – 0.14% 106
2016
Q1
$3.6M Sell
43,875
-52,347
-54% -$4.26M 0.15% 108
2015
Q4
$8.59M Buy
+96,222
New +$8.17M 0.17% 130

Other funds holding CAH

Handelsbanken Fonder's CAH Position: Q2 2026 in Review

Handelsbanken Fonder increased its Cardinal Health (CAH) stake by 13% in Q2 2026, buying an estimated $3.1M and bringing the position to 133,971 shares worth $31.8M. The position accounts for 0.09% of the portfolio, ranked #188.

Handelsbanken Fonder first reported a position in CAH in Q4 2015 and has held it in 32 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Handelsbanken Fonder held 133,971 shares of Cardinal Health worth $31.8M as of Q2 2026.
  • Handelsbanken Fonder bought 14,919 Cardinal Health shares in Q2 2026, an estimated $3.1M.
  • Cardinal Health made up 0.09% of Handelsbanken Fonder's portfolio in Q2 2026, its #188 holding.
  • Handelsbanken Fonder first reported a position in Cardinal Health in Q4 2015 and has held it in 32 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.